Objectives:
- Discuss the prevalence and potential risks with supplement and cannabis use by patients with cancer
- Identify common resources to screen supplements for potential treatment interactions
- identify commonly reported supplements and potential interactions with chemotherapy or targeted therapy
- Outline considerations for cannabidiol (CBD) or tetrahydrocannabinol (THC) use in patients with cancer
- Explain the oncology pharmacist approach to navigating supplement use in patients with cancer
Zoom Info:
Join from a PC, Mac, iPad, iPhone or Android device: Please click this URL to join. Passcode: Grand https://uwmadison.zoom.us/s/93795409378?pwd=SWRzR1R6cE1HN0dTM2lRbmQvV1NMdz09
Or One tap mobile: +13126266799,,93795409378# US (Chicago); +16469313860,,93795409378# US
Or join by phone: Dial(for higher quality, dial a number based on your current location). Webinar ID: 937 9540 9378
- US: +1 312 626 6799 or +1 646 931 3860 or +1 929 205 6099 or +1 301 715 8592 or +1 309 205 3325
- International numbers available: https://uwmadison.zoom.us/u/abcmjMjuM
Or an H.323/SIP room system: H.323: 162.255.37.11 (US West) or 162.255.36.11 (US East)
- Webinar ID: 937 9540 9378
- Passcode: 864581
SIP: 93795409378@zoomcrc.com; Passcode: 864581
Session date:
03/22/2023 - 8:00am to 9:00am CDT
Location:
In-person and Virtually
750 Highland Avenue (HSLC)
HSLC 1306
Madison, WI
53705
United States
See map: Google Maps
- 1.00 AAPA Category 1 CME
- 1.00 ACPE Contact Hours - Pharmacist
- 1.00 ACPE Contact Hours - Pharmacist Technician
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar:
Discloser List CME Internal Report
Presenter(s):
Dr. Lindsey Jung
Dr. Elizabeth Dow-Hillgartner